Clinical trial Recruiting at 1 site Interventional Ages 30 to 80

See if deep brain stimulation for Parkinson's changes thinking and movement and affects fall risk

Official title: Investigating the Increased Risk of Falls in Individuals With Parkinson's Disease Treated With Deep Brain Stimulation

Run by University of Alabama at Birmingham · NCT07725315 · Data updated 2026-11-12

This pilot study tests whether deep brain stimulation in people with Parkinson’s changes thinking or movement and whether those changes relate to how often they fall.

Quick facts

Study typeInterventional
Ages30 Years to 80 Years
SexAll
Enrollment20 (estimated)
SponsorUniversity of Alabama at Birmingham
Academic / other
Locations1 site (Homewood, Alabama)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedNovember 1, 2027
Study endsNovember 1, 2027
Registry record updatedOctober 26, 2026
Trial IDNCT07725315 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 30-80 with Parkinson’s disease who are electing DBS surgery as part of routine care and are able to walk and attend follow-up visits.

Probably not a fit

Patients with DBS who are unable to walk or have medical contraindications to surgery may not experience benefit regarding falls or cognitive/motor changes studied.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study investigates cognitive and motor changes after deep brain stimulation (DBS) implantation in Parkinson’s disease patients and explores how these changes may influence fall risk. DBS is used as part of standard care to manage motor symptoms when medication is insufficient. The study aims to identify potential mechanisms contributing to falls and to lay groundwork for interventions that address post-DBS fall risk. It will assess participants over a defined follow-up period to observe changes in axial motor symptoms, balance, and related factors. The approach focuses on causal factors rather than comparing DBS to other treatments.

Why it matters

Potential benefit: If successful, the study could help clinicians tailor DBS management to reduce fall risk and improve quality of life for people with Parkinson’s disease.

How similar studies have gone: Prior research on DBS and balance has mixed results; this study addresses a gap by examining causal factors of fall risk after DBS implantation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 30-80, patient has elected to undergo DBS surgery as part of routine care, cleared for deep brain stimulation surgery as part of routine care by the movement disorders committee. Refractory motor symptoms such as dyskinesias, wearing off, and/or motor fluctuations, causing significant disability, despite reasonable attempts at medical management, as determined by the consensus DBS committee, able to walk, Patient is available for follow-up over the length of the study

Exclusion Criteria: Patient's insurance will not cover the costs of surgery with investigational devices, Medical contraindications such as current uncontrolled hypertension, heart disease, coagulopathy, or other conditions contraindicating DBS surgery or stimulation, self-report of lack of clear levodopa response, requires a walker or wheelchair for mobility

\-

Where it's running

  • UAB WHARF at Lakeshore
    Homewood, Alabama, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.